Oscar Health Bundle
Who Owns Oscar Health?
Oscar Health's ownership structure shifted significantly with its IPO on March 3, 2021. This transition made its shares available to a wider investor base.
Understanding who holds stakes in Oscar Health is key to grasping its strategic direction and accountability in the health tech sector.
Discover the key stakeholders in Oscar Health's ownership.
Founded in 2012, Oscar Health, Inc. aims to simplify healthcare through technology. As of March 31, 2025, the company serves approximately 2 million members across 18 states. In 2024, Oscar Health reported its first profitable year with a net income of $25.4 million on total revenue of $9.2 billion. For 2025, the company projects total revenue between $11.2 billion and $11.3 billion. This growth trajectory is influenced by its ownership dynamics, including the impact of its Oscar Health PESTEL Analysis.
Who Founded Oscar Health?
Oscar Health was established in 2012 by Joshua Kushner, Kevin Nazemi, and Mario Schlosser, who were classmates at Harvard Business School. The company's inception was driven by Joshua Kushner's personal experience with the difficulties of navigating health insurance, leading to a vision for a more accessible and technologically advanced healthcare system. Mario Schlosser currently serves as CEO and President of Technology, while Joshua Kushner holds positions as Co-Founder, Vice Chairman, and Director. Kevin Nazemi is no longer in an executive role at the company.
| Founder | Current Role |
| Joshua Kushner | Co-Founder, Vice Chairman, Director |
| Mario Schlosser | CEO, President of Technology |
| Kevin Nazemi | No longer an executive |
Founding Vision
The company was founded with the goal of simplifying the health insurance process through technology. This vision was a key factor in attracting early investment and shaping the company's member-centric approach.
Early Funding
Initial seed funding occurred in 2013, followed by a significant $80 million round in 2014. This funding came from prominent early investors such as General Catalyst Partners, Khosla Ventures, and Breyer Capital.
Pre-IPO Investment
Before its initial public offering, the company secured substantial investments from Fidelity, totaling $400 million, and Alphabet (Google Capital), which invested $375 million. These investments fueled expansion into key markets.
Market Expansion
The capital raised enabled Oscar Health to establish its presence in markets including New York, New Jersey, California, and Texas. This strategic expansion was critical for its growth trajectory.
Parent Company Ownership
At its inception, the firm's parent company, Thrive Partners III, was reportedly owned by Joshua Kushner and his brother Jared. This early structure provided the initial framework for the company's operations.
Founder Equity Details
Specific details regarding the initial equity distribution among the founders or the precise terms of vesting and buy-sell agreements from the company's earliest private stages are not publicly disclosed.
The founding team's commitment to leveraging technology to simplify healthcare was a cornerstone in attracting early investment, aligning financial backing with the company's innovative and member-focused strategy. Understanding the Target Market of Oscar Health is crucial to appreciating the company's strategic direction and investor appeal.
Key Early Investors
Major investors in the company's early stages included General Catalyst Partners, Khosla Ventures, Breyer Capital, Fidelity, and Alphabet (Google Capital). These entities played a significant role in the company's initial growth and market penetration.
- General Catalyst Partners
- Khosla Ventures
- Breyer Capital
- Fidelity
- Alphabet (Google Capital)
Oscar Health SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
How Has Oscar Health’s Ownership Changed Over Time?
Oscar Health's ownership structure evolved significantly with its Initial Public Offering (IPO) on March 3, 2021. This event on the New York Stock Exchange, under the ticker OSCR, introduced a broad base of public shareholders and raised approximately $1.4 billion.
| Event | Date | Impact on Ownership |
| Initial Public Offering (IPO) | March 3, 2021 | Transitioned from private to public ownership, introducing public shareholders. |
| CEO Change | Early 2023 | Mark Bertolini joined with a focus on profitability, influencing strategic decisions. |
As of August 19, 2025, Oscar Health has a substantial institutional investor base, with 604 institutional owners holding 211,899,444 shares. Institutional ownership represented 77.13% of the company as of April 9, 2025, while insider ownership was 4.05%. Prominent institutional shareholders include Vanguard Group Inc, BlackRock, Inc., and T. Rowe Price Investment Management, Inc. Thrive Capital Management, LLC, linked to co-founder Joshua Kushner, remains a significant stakeholder, indicating continued influence from founding investors. The company's public status has led to increased scrutiny and a stronger emphasis on profitability, a key objective under CEO Mark Bertolini's leadership since early 2023.
Key Oscar Health Stakeholders
Oscar Health's ownership is primarily held by institutional investors, with significant stakes also retained by insiders and founding entities.
- Institutional Ownership: 77.13% (as of April 9, 2025)
- Insider Ownership: 4.05%
- Major Institutional Investors: Vanguard Group Inc, BlackRock, Inc., T. Rowe Price Investment Management, Inc.
- Significant Founding Investor: Thrive Capital Management, LLC
- Publicly Traded: Yes, on the New York Stock Exchange (OSCR)
Oscar Health PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
Who Sits on Oscar Health’s Board?
The current Board of Directors for Oscar Health, as of the April 25, 2025 proxy statement, comprises ten nominated directors. This group includes key figures such as CEO Mark T. Bertolini, Chairman Jeffery H. Boyd, and Co-Founders Joshua Kushner (Vice Chairman) and Mario Schlosser (President of Technology), alongside other experienced individuals.
| Director Name | Role | Affiliation/Key Position |
|---|---|---|
| Mark T. Bertolini | Director | Chief Executive Officer |
| Jeffery H. Boyd | Director | Chairman of the Board |
| William Gassen III | Director | |
| Joshua Kushner | Director | Co-Founder, Vice Chairman |
| Laura Lang | Director | |
| David Plouffe | Director | |
| Siddhartha Sankaran | Director | |
| Mario Schlosser | Director | Co-Founder & President of Technology |
| Vanessa A. Wittman | Director |
Oscar Health's voting power is significantly influenced by its dual-class share structure. Class A common stock carries one vote per share, while Class B common stock holds 20 votes per share. This structure, which will transition to a one-share-one-vote system in 2028 due to a sunset provision from its 2021 IPO, currently grants substantial voting control to holders of Class B shares, particularly Thrive Capital. As of April 10, 2024, the company had 201,466,384 shares of Class A and 35,514,201 shares of Class B outstanding.
Understanding Oscar Health's Governance
The governance of Oscar Health is shaped by its board composition and its unique share structure. This framework influences who controls the company's strategic direction and decision-making processes.
- Co-founders maintain board representation, ensuring alignment with the company's initial vision.
- A dual-class share structure concentrates voting power with Class B shareholders.
- The current structure will revert to a single class of voting shares in 2028.
- No significant proxy battles or activist investor campaigns were reported for the 2024-2025 period.
- Understanding these dynamics is key to grasping Oscar Health ownership.
Oscar Health Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What Recent Changes Have Shaped Oscar Health’s Ownership Landscape?
Oscar Health has seen significant leadership transitions in early 2025, with key executives departing and new leadership joining. These changes occur against a backdrop of industry-wide challenges and the company's strategic focus on expanding its market presence and achieving profitability.
| Executive Role | Name | Effective Date |
|---|---|---|
| EVP and COO | Steven Wolin | February 5, 2025 |
| EVP and Chief Insurance Officer | Alessandrea Quane | March 3, 2025 |
| EVP and President of Oscar Insurance | Janet Liang | February 24, 2025 |
| Chief Legal Officer | Adam McAnaney | Successor to Ranmali Bopitiya |
Industry-wide trends are shaping Oscar Health's operational landscape and influencing its ownership profile indirectly. The anticipated expiration of Affordable Care Act (ACA) subsidies by the end of 2025 could lead to a significant number of individuals losing coverage, potentially impacting revenue streams across the sector. For Oscar Health, this, coupled with increased morbidity and utilization rates, has led to a higher Medical Loss Ratio (MLR) of 91.1% in Q2 2025, up from 79.0% in Q2 2024. Despite these headwinds, the company achieved its first profitable year in 2024 with a net income of $25.4 million and has reaffirmed its 2025 revenue projections between $11.2 billion and $11.3 billion, with a forward-looking confidence in returning to overall profitability by 2026. The company is also focused on growth, planning to operate in 504 markets across 18 states in 2025. Understanding the company's Brief History of Oscar Health provides context for these ongoing developments.
Leadership Transitions
Key executive departures and new appointments in early 2025 signal a period of strategic realignment for the company.
Financial Performance Outlook
Despite industry challenges, the company achieved profitability in 2024 and projects continued revenue growth and a return to overall profitability by 2026.
Market Expansion Strategy
The company is actively expanding its market footprint, aiming to reach 504 markets across 18 states in 2025.
Industry Impact on MLR
Increased morbidity and utilization rates have driven the Medical Loss Ratio (MLR) to 91.1% in Q2 2025, a notable increase from the previous year.
Oscar Health Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Brief History of Oscar Health Company?
- What is Competitive Landscape of Oscar Health Company?
- What is Growth Strategy and Future Prospects of Oscar Health Company?
- How Does Oscar Health Company Work?
- What is Sales and Marketing Strategy of Oscar Health Company?
- What are Mission Vision & Core Values of Oscar Health Company?
- What is Customer Demographics and Target Market of Oscar Health Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.